The pharma industry's free speech stand in a whistleblower lawsuit against
The feds are responding to a brief filed by the industry trade group , which argued that drugmakers should be able to talk up off-label uses of their products, as long as that talk is truthful. It's a right, the trade group said.
http://www.fiercepharmamarketing.com/story/free-speech-phrma-not-label-marketing-case-feds-say/2014-09-10?utm_medium=nl&utm_source=internal
? Not so fast, says the . doesn't protect speech that spawns illegal conduct, federal prosecutors say in their own brief in the case.The feds are responding to a brief filed by the industry trade group , which argued that drugmakers should be able to talk up off-label uses of their products, as long as that talk is truthful. It's a right, the trade group said.
http://www.fiercepharmamarketing.com/story/free-speech-phrma-not-label-marketing-case-feds-say/2014-09-10?utm_medium=nl&utm_source=internal
No comments:
Post a Comment